Sell 2/5/2025Upgraded
Sagimet Biosciences Inc. (SGMT) was upgraded to D- from E+ on 2/5/2025 due to an increase in the volatility index, growth index and valuation index.

Sell 1/21/2025Downgrade
Sagimet Biosciences Inc. (SGMT) was downgraded to E+ from D- on 1/21/2025 due to a decline in the volatility index.

Sell 1/6/2025Upgraded
Sagimet Biosciences Inc. (SGMT) was upgraded to D- from E+ on 1/6/2025 due to a noticeable increase in the total return index and volatility index.

Sell 6/5/2024Downgrade
Sagimet Biosciences Inc. (SGMT) was downgraded to E+ from D- on 6/5/2024 due to a decline in the total return index and volatility index.

Sell 4/1/2024Upgraded
Sagimet Biosciences Inc. (SGMT) was upgraded to D- from E on 4/1/2024 due to an increase in the volatility index, growth index and total return index. Earnings per share increased from -$0.3492 to -$0.3476.

Sell 1/4/2024Upgraded
Sagimet Biosciences Inc. (SGMT) was upgraded to E from E- on 1/4/2024 due to a significant increase in the solvency index, efficiency index and growth index. Total capital increased 499.22% from $16.35M to $97.98M, the quick ratio increased from 3.5 to 20.17, and earnings per share increased from -$35.801 to -$0.35.

Sell 10/6/2023None
Sagimet Biosciences Inc. (SGMT) was downgraded to E- from U on 10/06/2023.